VenusX Shines at ASTRO 66th Annual ASTRO Meeting
The 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO) was successfully held in Washington, USA from September 29 to October 2, 2024.

LinaTech, with 30 years of expertise in radiotherapy, participates in ASTRO every year. On this global stage, the company has launched many innovative products including radiotherapy treatment planning systems (TPS), electric multi-leaf collimators (MLC) and image verification systems (IVS). This year is particularly remarkable, as the FDA-cleared VenusX medical linear accelerator made a brilliant debut, kicking off global sales. During the exhibition, old and new friends gathered, with professors and experts offering guidance, signaling a promising future for LinaTech.
As a vital cancer treatment modality, the radiotherapy market has achieved substantial growth over the past years. The global market size of medical linear accelerators reached RMB 25.876 billion in 2023. The market is projected to grow at an annual rate of 7%, reaching USD 10 billion by 2025. Varian and Elekta occupy 90% of the global market in this sector. LinaTech has stepped onto the international arena and will compete head-to-head with top industry players in the future.

In the age of globalization, sci-tech innovation advances rapidly. We keep pace with the times, continuously develop new technologies and innovative products for radiotherapy, dare to challenge on the broad global market, scale new heights and forge ahead.

Recommended Reading
Hotline:+86 10 67888916
Time:8:00 - 18:00